United Neuroscience to Present at CNS Summit 2017

DUBLIN, Nov. 13, 2017 /PRNewswire/ -- United Neuroscience (UNS), a clinical stage biotechnology company dedicated to developing best-in-class therapies for Alzheimer's disease, neurodegenerative disorders and orphan indications in neurology, announced today that Ajay Verma, M.D., Ph.D., chief medical officer, will present at the CNS Summit 2017 being held Nov. 16-18, 2017, in Boca Raton, Florida.

"We recognize that successfully addressing the challenge of treatment for neurological disease will require an ecosystem of global leaders in the biopharmaceutical industry," said Ajay Verma, M.D., Ph.D., chief medical officer of UNS and member of the CNS Summit Leadership Council for the Clinical Trials of the Future (CTF) initiative. "We are proud to join the speakers and panelists presenting at this year's CNS Summit to share knowledge that will help accelerate the development of new treatments across the field."

Details of the presentation are as follows:

About United Neuroscience

United Neuroscience is a clinical-stage biotech company dedicated to the development of best-in-class immunotherapeutics. Headquartered in Dublin, Ireland, with operations in Taiwan and the United States, United Neuroscience was founded to address the global social and economic burden of neurological disease. United Neuroscience is developing therapeutic and preventive vaccines against endogenous proteins implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease and chronic traumatic encephalopathy (CTE) as well as orphan indications in neurology. For more information please visit www.unitedneuroscience.com.

Contacts

David Schull or Rich Allan
Russo Partners, LLC
(212) 845-4271
(646) 942-5588
[email protected]
[email protected]

SOURCE United Neuroscience

Related Links

http://www.unitedneuroscience.com